Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-25-001763
Filing Date
2025-12-19
Accepted
2025-12-19 17:20:19
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 e665061_3-roberts.html 3  
1 e665061_3-roberts.xml 3 14476
  Complete submission text file 0001193805-25-001763.txt   15837
Mailing Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA
Business Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Roberts Joseph (Reporting) CIK: 0002101782 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38942 | Film No.: 251588573